Effects of the Chaperone Inducer U133 on Sleep–Wake Cycle Temporal Characteristics and Spatial Memory

U133, a chaperone inducer synthesized on the basis of echinochrome A, has antitumor, antioxidant and neuroprotective activity. The breadth of its therapeutic effects arouses great interest in this compound as a potential precursor of drugs. However, the functional spectrum of biological activity of...

Full description

Saved in:
Bibliographic Details
Published in:Journal of evolutionary biochemistry and physiology 2022-07, Vol.58 (4), p.1214-1224
Main Authors: Ekimova, I. V., Kurmazov, N. S., Pazi, M. B., Chernyshev, M. V., Polonik, S. G., Pastukhov, Yu. F.
Format: Article
Language:English
Subjects:
Aging
Animal Physiology
Biochemistry
Biological activity
Biomedical and Life Sciences
Central nervous system
Evolutionary Biology
Experimental Papers
Hsp70 protein
Hypothalamus
Injection
Life Sciences
Locus coeruleus
Mesencephalon
Neuroprotection
Preoptic area
Short term memory
Sleep
Sleep and wakefulness
Spatial memory
Substantia nigra
Ventral tegmentum
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:U133, a chaperone inducer synthesized on the basis of echinochrome A, has antitumor, antioxidant and neuroprotective activity. The breadth of its therapeutic effects arouses great interest in this compound as a potential precursor of drugs. However, the functional spectrum of biological activity of U133 remains incomplete. This study aimed to find out whether a U133-induced increase in the chaperone Hsp70 brain level is associated with changes in the sleep–wake cycle and spatial working memory in Wistar rats under natural physiological conditions. Intraperitoneal injection of U133 led to an increase in Hsp70 (HSPA1) levels in the brain structures involved in the mechanisms of sleep–wake cycle regulation and memory formation, such as the locus coeruleus, preoptic area of the hypothalamus, substantia nigra pars compacta, ventral tegmental area of the midbrain). An increase in brain Hsp70 levels was associated with a 1.7-fold increase in the duration of rapid-eye movement sleep (REMS) during the period from the 12th to 24th h after U133 injection, suggesting that the effect of U133 on REMS representation is mediated via Hsp70. Although REMS can affect the formation of different memory modalities, we found no significant effect of U133 on spatial working memory. U133 can be recommended for further investigation of the spectrum of its biological activity in order to predict its therapeutic efficacy in various pathologies of the central nervous system and aging, when sleep is impaired and chaperone expression in the brain is diminished.
ISSN:0022-0930
1608-3202
DOI:10.1134/S002209302204024X